NXNN - Nexeon MedSystems Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.84
0.00 (0.00%)
As of 3:07PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.84
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume1,350
Market Cap23.197M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire19 days ago

    Nexeon MedSystems Announces Fourth Quarter and Full Year Results

    DALLAS, April 05, 2018-- Nexeon MedSystems Inc a neurostimulation medical device company, announced today financial results for the fourth quarter and full year ended December 31, 2017.. Manufacturing ...

  • ACCESSWIRE4 months ago

    SeeThruEquity Issues Update on Nexeon MedSystems, Inc. (OTCQB: NXNN)

    NEW YORK, NY / ACCESSWIRE / December 21, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has ...

  • Nexeon MedSystems Provides Shareholder Update
    PR Newswire5 months ago

    Nexeon MedSystems Provides Shareholder Update

    Company to Host Conference Call November 20, 2017 4pm CST DALLAS , Nov. 20, 2017 /PRNewswire/ -- Nexeon MedSystems Inc. (OTCQB: NXNN, "Nexeon", "the Company"), is providing shareholders ...

  • Nexeon MedSystems Begins Trading as NXNN
    PR Newswire7 months ago

    Nexeon MedSystems Begins Trading as NXNN

    "I'm proud of our management team for implementing and delivering on innovative financing strategies in much the same fashion as our engineers do," said Nexeon CEO Will Rosellini. In June 2017, the Securities and Exchange Committee (SEC) declared effective the Company's S-1 Registration Statement. The S-1 registered 5,332,496 shares of the Company's common stock.

  • PR Newswire8 months ago

    Nexeon MedSystems "OTCQB:NXNN" Acquires Belgian Manufacturer

    LIEGE, Belgium, Sept. 6, 2017 /PRNewswire/ -- Nexeon MedSystems ("Nexeon" or "the Company") (NXNN) announced today that it has exercised its option to acquire Nexeon Medsystems Belgium, SPRL ("NMB").  This Belgian-based company has been operating since 2013 developing neurostimulation products. NMB recently acquired Medi-Line, a Belgian medical device manufacturer with financing support provided by KBC and CBC Bank.  Medi-Line has expertise in active and non-active implants, and it has been profitable for its complete 25-year corporate history. For more information about the transaction, please review the Form 8-K.